Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation

Molecular Medicine

Volumn 14, Issue 11-12, 2008, Pages 665-674

  Catera, Rosa ^a   Silverman, Gregg J ^b   Hatzi, Katerina ^a   Seiler, Till ^a   Didier, Sebastien ^a   Zhang, Lu ^a   Hervé, Maxime ^c   Meffre, Eric ^c   Oscier, David G ^d   Vlassara, Helen ^e   Scofield, R Hal ^f   Chen, Yifang ^b   Allen, Steven L ^a,g   Kolitz, Jonathan ^a   Rai, Kanti R ^a,g   Chu, Charles C ^a,h   Chiorazzi, Nicholas ^a,g  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; MONOCLONAL ANTIBODY;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL EXPANSION; CELL STRUCTURE; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IGHV GENE; LEUKEMIA CELL; LYMPHOCYTE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; OXIDATION KINETICS; PRIORITY JOURNAL; STRUCTURAL GENE; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; APOPTOSIS; AUTOANTIGENS; AUTOIMMUNITY; CELL LINE, TUMOR; EPITOPES; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTES; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION;

EID: 55749114077     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2008-00102.Catera     Document Type: Article

References (54)

1. Rai KR. (1997) Chronic lymphocytic leukemia in the elderly population. Clin. Geriatr. Med. 13:245-9.
2. Damle RN, et al. (2002) B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99:4087-93.
3. Chiorazzi N, Ferrarini M. (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Ann. Rev. Immunol. 21:841-94.
4. Stevenson F, Caligaris-Cappio F. (2004) Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103:4389-95.
5. Chiorazzi N, Rai KR, Ferrarini M. (2005) Chronic lymphocytic leukemia. N. Engl. J. Med. 352:804-15.
6. Fais F, et al. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102:1515-25.
7. Damle RN, et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840-7.
8. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-54.
9. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG. (1987) The role of clonal selection and somatic mutation in autoimmunity. Nature 328:805-11.
10. Casciola-Rosen LA, Anhalt G, Rosen A. (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317-30.
11. Radic M, Marion T, Monestier M. (2004) Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol. 172:6692-700.
12. Shaw PX, Goodyear CS, Chang MK, Witztum JL, Silverman GJ. (2003) The autoreactivity of antiphosphorylcholine antibodies for atherosclerosis- associated neo-antigens and apoptotic cells. J. Immunol. 170:6151-7.
13. Chang MK, et al. (2004) Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200:1359-70.
14. Masmoudi H, Mota-Santos T, Huetz F, Coutinho A, Cazenave PA. (1990) All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int. Immunol. 2:515-20.
15. Broker BM, et al. (1988) Chronic lymphocytic leukemic cells secrete multispecific autoantibodies. J. Autoimmun. 1:469-81.
16. Sthoeger ZM, et al. (1989) Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J. Exp. Med. 169:255-68.
17. Borche L, Lim A, Binet JL, Dighiero G. (1990) Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 76:562-9.
18. Herve M, et al. (2005) Unmutated and mutated chronic lymphocytic leukemia derive from common self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 115:1636-43.
19. Wardemann H, et al. (2003) Predominant autoantibody production by early human B cell precursors. Science 301:1374-7.
20. Bird DA, et al. (1999) Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc. Natl. Acad. Sci. U. S. A. 96:6347-52.
21. Silverman GJ, et al. (2008) Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin. Exp. Immunol. 153:102-16.
22. Tobin G, et al. (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104:2879-85.
23. Messmer BT, et al. (2004) Multiple distinct sets of stereotyped antigen receptors indicate a key role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200:519-25.
24. Widhopf GF 2nd, et al. (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104:2499-504.
25. Stamatopoulos K, et al. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109:259-70.
26. Murray F, et al. (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 111:1524-33.
27. Tan EM. (1994) Autoimmunity and apoptosis. J. Exp. Med. 179:1083-6.
28. Guilbert B, Dighiero G, Avrameas S. (1982) Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J. Immunol. 128:2779-87.
29. Esterbauer H, Schaur RJ, Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128.
30. Chou MY, et al. (2008) Oxidation-specific epitopes are important targets of innate immunity. J. Intern. Med. 263:479-88.
31. Radic MZ, et al. (1993) Residues that mediate DNA binding of autoimmune antibodies. J. Immunol. 150:4966-77.
32. Lanemo Myhrinder A, et al. (2008) A new perspective: molecular motifs on oxidized-LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 111:3838-48.
33. Sethi DK, Agarwal A, Manivel V, Rao KV, Salunke DM. (2006) Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response. Immunity 24:429-38.
34. Martin T, Crouzier R, Weber JC, Kipps TJ, Pasquali JL. (1994) Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J. Immunol. 152:5988-96.
35. Briles DE, et al. (1981) Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J. Exp. Med. 153:694-705.
36. Hatzi K, et al. (2006) B-cell chronic lymphocytic leukemia (B-CLL) cells express antibodies reactive with antigenic epitopes expressed on the surface of common bacteria. Blood 108:12a.
37. Landgren O, et al. (2007) Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 109:2198-201.
38. Solvason N, Kearney JF. (1992) The human fetal omentum: a site of B cell generation. J. Exp. Med. 175:397-404.
39. Martin F, Kearney J. (2000) B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory." Immunol. Rev. 175:70-9.
40. Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF. (1997) Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 9:27-41.
41. Li Y, Li H, Weigert M. (2002) Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195:181-8.
42. Rassenti LZ, Kipps TJ. (1997) Lack of allelic exclusion in B cell chronic lymphocytic leukemia. J. Exp. Med. 185:1435-45.
43. Klein U, et al. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194:1625-38.
44. Rosenwald A, et al. (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J. Exp. Med. 194:1639-47.
45. Dono M, et al. (2007) CD5(+) B cells with the features of subepithelial B cells found in human tonsils. Eur. J. Immunol. 37:2138-47.
46. Akira S, Takeda K, Kaisho T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-80.
47. Tian J, et al. (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8:487.
48. Lafyatis R, Marshak-Rothstein A. (2007) Toll-like receptors and innate immune responses in systemic lupus erythematosus. Arthritis Res. Ther. 9:222.
49. Chu CC, et al. (2008) Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize non-muscle myosin heavy chain IIA. Blood 2008, Sep 23 [Epub ahead of print].
50. Kato M, Fukuda H, Nonaka T, Imajoh-Ohmi S. (2005) Cleavage of nonmuscle myosin heavy chain-A during apoptosis in human Jurkat T cells. J. Biochem. 137:157-66.
51. Muller K, Dulku S, Hardwick SJ, Skepper JN, Mitchinson MJ. (2001) Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoprotein. Atherosclerosis 156:133-44.
52. Moisan E, Girard D. (2006) Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J. Leukoc. Biol. 79:489-98.
53. Shoeman RL, Hartig R, Traub P. (1999) Characterization of the nucleic acid binding region of the intermediate filament protein vimentin by fluorescence polarization. Biochemistry 38:16802-9.
54. Lefranc MP. (2004) IMGT-ONTOLOGY and IMGT databases, tools and Web resources for immunogenetics and immunoinformatics. Mol. Immunol. 40:647-60.